Single nucleotide polymorphisms at the LRRK2 locus have also been identified as PD risk factors through genome wide association studies and have recently been shown to lead to increased kinase activity in the sporadic disease (Chang et al., 2017; Di Maio et al., 2018; Nalls et al., 2014). Here, LRRK2 is linked to Parkinson disease.